Kinnate Biopharma Inc. (KNTE) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 2 Buy, 4 Hold.
The consensus price target is $30.00, representing an upside of 1032.1% from the current price $2.65.
KNTE Stock — 12-Month Price Forecast
$30.00
▲ +1,032.08% Upside
Average Price Target
Based on 6 Wall Street analysts offering 12-month price targets for Kinnate Biopharma Inc., the price target is $30.00.
The average price target represents a +1,032.08% change from the last price of $2.65.
KNTE Analyst Ratings
Hold
Based on 6 analysts giving stock ratings to Kinnate Biopharma Inc. in the past 3 months
